As of October 10, 2014, PneumRx completed enrollment for an IDE clinical study to evaluate the safety and effectiveness of a medical device for patients with emphysema: the RePneu® (say ‘RENEW’) Coil treatment. Coils are placed in the airways of the lung and work by compressing diseased portions of the lung, helping small airways stay open, so that breathing becomes easier and healthier parts of the lung can function more efficiently.
Thousands of patients have been successfully treated in European clinical studies and routine clinical practice. Patients treated with RePneu Coils may experience improvements in their ability to exercise, and lung function and quality of life.
315 patients participated in the RENEW Study, conducted in over 25 medical centers across North America, with a smaller number of sites in Europe.